About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Dr. Reddy's Laboratories Receives FDA Warning Over Three Manufacturing Facilities

by Dr. Trupti Shirole on November 8, 2015 at 6:27 PM
Font : A-A+

 Dr. Reddy's Laboratories Receives FDA Warning Over Three Manufacturing Facilities

The US Food and Drug Administration (FDA) has issued a warning to leading drug maker Dr. Reddy's Laboratories over inadequate quality control at API (active pharmaceutical ingredient) manufacturing facilities at Srikakulam in Andhra Pradesh and Miryalaguda in Telangana, as well as oncology formulation manufacturing facility at Duvvada, Visakhapatnam, also in Andhra Pradesh.

Dr. Reddy's Laboratories on Friday, November 7, 2015, has acknowledged having received a warning letter from the US FDA relating to its three manufacturing plants in Andhra Pradesh and Telangana. Reddy's also said, "We will respond with a comprehensive plan to the US Food and Drug Administration (FDA)."

Advertisement


Dr. Reddy's said, "The action followed inspections of these sites by the agency in November 2014 and January and February this year. It takes quality and compliance matters seriously and stands by its commitment to fully comply with the CGMP (current good manufacturing practice) quality standards across all its facilities."

G.V. Prasad, CEO at Dr Reddy's, said, "We will respond with a comprehensive plan to address these observations within the stipulated time-frame of 15 days. We will continue to actively engage with the agency to resolve these issues. We have also embarked on an initiative to revamp our quality systems and processes, as an organization-wide priority."

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Sinopril (2mg) (Lacidipine) Accident and Trauma Care Nutam (400mg) (Piracetam) Noscaphene (Noscapine) Indian Medical Journals Drug Interaction Checker Pregnancy Confirmation Calculator Diaphragmatic Hernia A-Z Drug Brands in India The Essence of Yoga
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Dr. Reddy's Laboratories Receives FDA Warning Over Three Manufacturing Facilities Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests